G. Sibley

发表

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

M. Dewhirst, D. Brizel, L. Prosnitz, 1997, International journal of radiation oncology, biology, physics.

Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?

M. Socinski, R. Clough, M. Anscher, 2005, International journal of radiation oncology, biology, physics.

The effect of patient-specific factors on radiation-induced regional lung injury.

R. Jaszczak, R. Coleman, M. Anscher, 1999, International journal of radiation oncology, biology, physics.

Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.

T G Turkington, M T Munley, D R Gilland, 1999, Lung cancer.

Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma

G. Sibley, 1998, Cancer.

Can Angiotensin-Converting Enzyme Inhibitors Protect against Symptomatic Radiation Pneumonitis?

M. Anscher, L. Marks, X. Fu, 2000, Radiation research.

Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.

M. Socinski, S. Zhou, M. Anscher, 2001, The oncologist.

The rationale and use of three-dimensional radiation treatment planning for lung cancer.

L. Marks, G. Sibley, 1999, Chest.

73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer.

P. Maguire, R. Clough, M. Anscher, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

73.6 G y a nd B eyond: H yperfractionate d, A ccelerated Radiotherapy f or N on-Small-Cell L ung C ancer

P. Maguire, R. Clough, M. Anscher, 2001 .

The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests

R. Jaszczak, R. Clough, L. Marks, 2000, Cancer.

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.

R. Weichselbaum, A. Mundt, H. Halpern, 1994, International journal of radiation oncology, biology, physics.

Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.

R. Weichselbaum, A. Mundt, Srinivasan Vijayakumar, 1995, International journal of radiation oncology, biology, physics.

Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.

D. Hallahan, R. Weichselbaum, A. Mundt, 1995, International journal of radiation oncology, biology, physics.

Physical and biological predictors of changes in whole-lung function following thoracic irradiation.

M T Munley, L B Marks, G C Bentel, 1997, International journal of radiation oncology, biology, physics.

Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?

R. Jaszczak, R. Coleman, M. Anscher, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A new three-dimensional dose distribution reduction scheme for tubular organs.

P. Maguire, G. Tracton, S. Zhou, 2000, Medical physics.

Clinical and dosimetric predictors of radiation-induced esophageal toxicity.

P. Maguire, S. Zhou, M. Anscher, 1999, International journal of radiation oncology, biology, physics.

Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium

M. Socinski, R. Clough, M. Anscher, 2004 .

Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.

R. Clough, L. Marks, J. Crawford, 2003, International journal of radiation oncology, biology, physics.

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.

D. Hallahan, R. Weichselbaum, A. Mundt, 1995, International journal of radiation oncology, biology, physics.

A neural network to predict symptomatic lung injury.

Joseph Y. Lo, Lawrence B. Marks, Michael T. Munley, 1999, Physics in medicine and biology.

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.

C. Shapiro, R. Weichselbaum, G. Chen, 1995, International journal of radiation oncology, biology, physics.

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

M. Anscher, L. Marks, T. Jamieson, 1998, International journal of radiation oncology, biology, physics.

Routine 3 D Treatment Planning : Opportunities , Challenges , and Hazards Review

L. Marks, G. Bentel, Sumin Zhou, 2017 .

Can W e P redict R adiation-Induce d C hanges i n P ulmonary Function B ased o n t he S um o f P redicted R egional Dysfunction?

R. Jaszczak, R. Coleman, M. Anscher, 2001 .

Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.

M. Socinski, R. Clough, M. Anscher, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Procedes et compositions de stimulation virale d'elimination de cellules

D. Hallahan, B. Roizman, G. Sibley, 1996 .

Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema.

D. Chinn, G. Sibley, T. Poyner, 2002, The British journal of dermatology.